Peer-influenced content. Sources you trust. No registration required. This is HCN.

MedPage TodayFDA Authorizes IL-1 Drug for Hospitalized COVID Patients

Anakinra (Kineret, Sobi) currently approved for rheumatoid arthritis and some rare disorders, was granted an emergency use authorization for a subgroup of COVID-hospitalized patients who are at risk of severe respiratory failure.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form